Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blood Transfusions and Adverse Events after Colorectal Surgery: A Propensity-Score-Matched Analysis of a Hen-Egg Issue.
Catarci M, Guadagni S, Masedu F, Montemurro LA, Ciano P, Benedetti M, Delrio P, Garulli G, Pirozzi F, Scatizzi M; Italian ColoRectal Anastomotic Leakage (iCral) Study Group. Catarci M, et al. Among authors: guadagni s. Diagnostics (Basel). 2023 Mar 2;13(5):952. doi: 10.3390/diagnostics13050952. Diagnostics (Basel). 2023. PMID: 36900095 Free PMC article.
Hypoxic pelvic perfusion with cisplatin and mitomycin C in multidisciplinary palliative treatment of patients with unresectable recurrent rectal cancer: a retrospective study.
Guadagni S, Fiorentini G, Palumbo P, Masedu F, Ricevuto E, Bruera G, Deraco M, Kusamura S, Sarti D, Fiorentini C, Gailhofer S, Clementi M. Guadagni S, et al. Minerva Chir. 2019 Aug;74(4):304-312. doi: 10.23736/S0026-4733.19.07896-9. Epub 2019 May 2. Minerva Chir. 2019. PMID: 31062943
Multidisciplinary palliation for unresectable recurrent rectal cancer: hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study.
Guadagni S, Fiorentini G, Mambrini A, Masedu F, Valenti M, Mackay AR, Sarti D, Ricevuto E, Clementi M, Catarci M, Lazzarin G, Bruera G. Guadagni S, et al. Oncotarget. 2019 Jun 11;10(39):1-13. doi: 10.18632/oncotarget.26972. eCollection 2019 Jun 11. Oncotarget. 2019. PMID: 31231460 Free PMC article.
248 results